LAR · Lithium Argentina AG

Current Thesis

Lithium Argentina’s financing-backed expansion story has failed its published price test: the 2026-09-18 weekly close of $5.77 breached $6.00, leaving the expected end-September development plan as a potential rebuilding event. The previous recovery thesis is invalidated; financing completion does not reverse that recorded outcome.

The material company update is the 2026-09-15 closing of Ganfeng’s $180 million strategic investment through an unsecured convertible note. That establishes financing completion, while the inference that financing would support an equity recovery failed the published price condition. Company announcement, September 15

The narrative is dead — this classification describes the published recovery leg, whose $6.00 weekly-close condition was breached on 2026-09-18. It does not describe the operating asset’s viability.

Bullish and bearish views on Lithium Argentina AG

The model's bull view on Lithium Argentina AG (LAR), in brief: Financing completion is now documented. The note closed on 2026-09-15 with a six-year maturity, a 4.0% annual coupon and a $12.50 conversion price. These are contractual financing terms; the conversion price is not an analyst valuation. September 15 announcement Operating cash… The bear view: The published structure has broken. The 2026-09-18 adjusted close of $5.77 is below the $6.00 weekly threshold published on 2026-09-05. The supplied market series also records a three-month decline of 35.7%; neither observation establishes a recovery base. Financing includes… Both cases follow in full.

Bull Case

• Financing completion is now documented. The note closed on 2026-09-15 with a six-year maturity, a 4.0% annual coupon and a $12.50 conversion price. These are contractual financing terms; the conversion price is not an analyst valuation. September 15 announcement
• Operating cash generation remains evidence. Cauchari-Olaroz generated $141 million of free cash flow from operations in Q2 2026, reported on 2026-08-11. Lithium Argentina owns 44.8% of the operating entity; the operating figure describes the entire joint venture. Q2 results
• Analyst interpretation was not uniformly negative. Stifel raised its price target to $13 from $11 on 2026-08-25, citing the extended debt maturity profile and growth optionality, according to The Fly. This corrects the previous note’s account of the latest analyst actions as exclusively cuts. The Fly, August 25

Bear Case

• The published structure has broken. The 2026-09-18 adjusted close of $5.77 is below the $6.00 weekly threshold published on 2026-09-05. The supplied market series also records a three-month decline of 35.7%; neither observation establishes a recovery base.
• Financing includes potential equity dilution. The 2026-09-15 instrument is convertible debt, so the financing cannot be described simply as non-dilutive. Conversion would create equity dilution under its contractual terms; issuance of the note does not establish that conversion has occurred. September 15 announcement
• Tax approval leaves permitting unfinished. The 2026-08-11 release reported approval under Argentina’s Large Investment Incentive Regime (RIGI), but described the Stage 2 environmental approval process as underway. The earlier claim that permitting was already cleared was too broad. Q2 results

Setup & Price Structure

The supplied split/dividend-adjusted series records a $5.77 close on 2026-09-18, 51.1% below its 52-week high. The 14-day relative strength index (RSI) was 25.9. These are measurements of price weakness; they do not establish that selling is exhausted.

The former $6.00 thesis boundary has been breached. The $7.00 weekly recovery condition identified in the 2026-09-05 note remains a possible rehabilitation test, rather than established support. No replacement downside threshold is supported by the supplied chart evidence.

Positioning evidence is limited. The September 15 convertible issuance is observable, but no dated retail-participation, short-interest, insider-transaction or moving-average series establishes crowding. The supplied price decline also does not support describing this issuance as occurring into strength.

Catalyst Calendar (next 30 days)

• ~2026-09-30, estimated: Stage 2 development plan. The 2026-08-11 release expected an update around the end of Q3, including a proposed initial 10,000 tonnes-per-year lithium carbonate equivalent facility using direct lithium extraction (DLE). September 30 represents that approximate window, not a confirmed publication appointment. Publication would provide evidence for reassessing the expansion case; a disclosed deferral would defeat the near-term timing premise. Q2 results

What Would Change Our Mind

Loss of the published recovery structure is already observable: a weekly close below $6.00 occurred at $5.77 on 2026-09-18. Moving the boundary lower would change the original thesis rather than preserve it.

A separate rehabilitation case would require the expected end-September plan to disclose development costs, throughput and timing, accompanied by a weekly close above the previously published $7.00 recovery condition. Without both company evidence and price confirmation, the September 18 failure remains the operative finding. These are conditions for reassessment, not a forecast that recovery will occur.

Correlation Notes

This remains a single-name assessment. The 2026-09-05 note inferred that lithium-price transmission had broken in both directions, but its sparse paired observations do not establish a stable correlation or its disappearance. The sample is too small to support that claim.

No contemporaneous commodity series accompanies the 2026-09-18 equity close. The latest decline therefore cannot be attributed to lithium prices, Argentine conditions or financing dilution on the available evidence. The observable conclusion is narrower: the equity breached its published level after the September 15 financing announcement.